BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 2446018)

  • 1. Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors.
    Carter GE; Lieskovsky G; Skinner DG; Daniels JR
    J Urol; 1987 Dec; 138(6):1397-401. PubMed ID: 2446018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of retroperitoneal lymph node dissection in advanced testicular seminoma.
    Kamat MR; Kulkarni JN; Tongaonkar HB; Ravi R
    J Surg Oncol; 1992 Sep; 51(1):65-7. PubMed ID: 1381455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advanced non-seminoma germinal tumors of the testicle. Therapeutic strategy and method of action of chemotherapy].
    Bassoulet J; Raoul Y; Garetta L
    Ann Urol (Paris); 1986; 20(1):35-42. PubMed ID: 2423016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for germ cell tumors.
    Motzer RJ; Bosl GJ
    Urol Clin North Am; 1987 May; 14(2):389-98. PubMed ID: 2437682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 7. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with clinical stage I or II nonseminomatous germ cell tumors of the testis. Evolving therapeutic options.
    Richie JP; Socinsky MA; Fung CY; Brodsky GL; Kalish LA; Garnick MB
    Arch Surg; 1987 Dec; 122(12):1443-5. PubMed ID: 2446590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors.
    Bajorin DF; Herr H; Motzer RJ; Bosl GJ
    Semin Oncol; 1992 Apr; 19(2):148-58. PubMed ID: 1372757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual mass after chemotherapy for seminoma: changing concepts of management.
    Herr HW; Bosl G
    J Urol; 1987 Jun; 137(6):1234-5. PubMed ID: 2438431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of complete remission obtained with etoposide cis-platinum combination chemotherapy in advanced testicular cancer].
    Iinuma S; Yamamoto H; Hagiwara M; Nakazono M
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):293-6. PubMed ID: 1689134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of patients with stages I and II nonseminomatous testicular cancer.
    Fraley EE; Narayan P; Vogelzang NJ; Kennedy BJ; Lange PH
    J Urol; 1985 Jul; 134(1):70-3. PubMed ID: 2409301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
    Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
    Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
    J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of disseminated germ cell tumors of the testis].
    Tiuliandin SA
    Sov Med; 1987; (11):78-81. PubMed ID: 2451298
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of bilateral testicular tumors showing remarkable regression of huge metastatic tumors after VAB-6 combined chemotherapy].
    Nakashima T; Nakajima K; Yokoyama O; Sugata T; Tokunaga S; Nitta M; Hisazumi H
    Hinyokika Kiyo; 1988 Oct; 34(10):1823-8. PubMed ID: 2469323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
    Loehrer PJ; Hui S; Clark S; Seal M; Einhorn LH; Williams SD; Ulbright T; Mandelbaum I; Rowland R; Donohue JP
    J Urol; 1986 Jun; 135(6):1183-9. PubMed ID: 2423708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.